Navigation Links
Cyclodextrin enhances room temperature phosphorescence


Abstract
Cyclodextrin-enhanced room-temperature phosphorescence (CD-RTP) is an analytical technique that offers well-resolved spectra and subpicogram detection limits. When polynuclear aromatic hydrocarbons (PAHs) are included in cyclodextrin molecules in the presence of a heavy-atom moiety such as 1,2-dibromoethane, they exhibit intense, well-defined phosphorescence emissions, often with distinct vibrational structure. Moreover, the cyclodextrin moiety inhibits quenching of PAH phosphorescence by O2 present in the bulk solution.


Introduction
Cyclodextrins (CDs) are made up of glucose monomers coupled to form a rigid, conical structure with an interior hydrophobic cavity. The most common CDs, denoted by α, β, and γ, are composed, respectively, of six, seven, and eight monomers. Initially, each CD contains one or more water molecules, produced during the monomer coupling. Because these included water molecules are easily displaced by hydrophobic species that will fit into the CD interior, cyclodextrins have a unique ability to form stable inclusion complexes with a variety of molecules.

This inclusion capability has led to an important use of cyclodextrins in luminescence spectroscopy. Cyclodextrins have been found to enhance fluorescent and phosphorescent emissions from molecules present in the CD cavity.1,2,3,4,5 Of particular interest is the phenomenon of cyclodextrin-enhanced room-temperature phosphorescence (CD-RTP), which suggests a highly-selective analytical technique based on the molecular geometry of the lumiphor.

Chromophores such as polynuclear aromatic hyrdocarbons (PAHs) exhibit virtually no phosphorescence in conventional fluid media. Scypinski and Cline Love report, however, that intense room-temperature phosphorescence occurs when these well-known carcinogens are present, with an external heavy atom, in the cavity of cyclodextrin.4 Figure 1 depicts the inclusion of a phenanthrene molecule within the cavity of a β-CD. Scypinski and Cline Love also have observed CD-RTP in nitrogen heterocycles and bridged biphenyls.5


A description of the experiments with PAHs will serve to illustrate the technique of CD-RTP, and provide a basis for assessing its advantages.


Experimental Method
Each PAH analyte was dissolved in either methanol or acetone, after which the solvent was gently evaporated. Addition of a 0.10.5-mL aliquot of 1,2-dibromoethane (DBE) was followed by dilution with 0.01-M aqueous CD solution. Upon vigorous shaking, the complex was formed. The cloudy solution obtained was then deoxygenated for fifteen minutes with nitrogen gas prepurified in an Alltech Oxy-Trap.

All spectra were taken on a SPEX FLUOROLOG spectrophotometer with double excitation and emission monochromators. A 450-W xenon CW lamp was used as the excitation source, and a cooled R928 photomultiplier (PMT) tube as the detector. Slits were set to 14.4 nm (excitation) and 3.6 nm (emission). The scan rate was 1 nm s1. All emission spectra were corrected for fluctuations in the intensity of the lamp and PMT responses.


Results and Discussion
The investigation showed the CD-RTP technique to be extremely sensitive, producing intense, well-structured phosphorescence signals at nanomolar concentrations. Detection limits of two typical phosphors, phenanthrene and acenaphthene, were estimated at 5 1013 M and 1 1011 M, respectively. Although the excited triplet state is known to be susceptible to oxygen quenchers, inclusion of the lumiphor inside the CD cavity was observed to offer some protection against quenching by oxygen molecules in the bulk solution. In these experiments, 10% to 40% of the RTP remained after aeration of the samplea signal still strong enough for analytical purposes.

The success of CD-RTP with PAHs depends on the formation of a proposed three-component complex of CD, lumiphor, and external heavy atom. The internal cavity of the CD must be large enough to accommodate both the lumiphor, which must fit at least partially inside, and the heavy atom.


Figure 2 shows the luminescence spectra for phenanthrene included in β-CD, with and without the addition of the heavy-atom DBE. Because the heavy-atom moiety enhances spin-orbit coupling and the rate of inter-system crossings, addition of DBE serves to quench much of the fluorescence while intensifying the phosphorescence.

The physical dimensions of the CD cavities, relative to the geometry of the individual PAH, determined the most effective CD form for each analyte. For example, although the phenanthrene molecule will fit inside the cavity of the α-CD, which has an inner diameter of 0.6 nm, there is apparently not enough room remaining to accommodate the DBE molecule. Both phenanthrene and DBE molecules, however, can be included in the larger β-CD cavity, which has an inner diameter of 0.78 nm. Figure 3 compares the luminescence spectra for the same solution of phenanthrene and DBE in α- and β-CD. Anthracene, which is larger than phenanthrene, showed only weak phosphorescence in βCD, but γ-CD, with an inner diameter of 1.0 nm, induced stronger emissions.


The geometrical limitations imposed by CDRTP may be exploited as a selective means of analysis based on molecular size and shape. For example, it is possible to discriminate between naphthalene, which can be induced to phosphoresce in β-CD, and its bulkier derivative 1-phenylnaphthalene, which shows only fluorescence under the same conditions.

In these experiments, the phosphorescence intensity of the included PAH was found to depend on the concentration of the heavy-atom moiety and on the concentration of CD. Figure 4 illustrates the relationship of the phosphorescence intensity of phenanthrene to the concentration of DBE. As long as the concentration of DBE is low with respect to that of CD, DBE molecules added into the solution are incorporated in the trimolecular inclusion complex, causing a sharp increase in phosphorescence intensity. When the DBE concentration reaches that of the CD, so that complexation is virtually complete, further addition of DBE enhances the phosphorescence only slightly.


Figure 5 demonstrates the dependence of phosphorescence intensity on the concentration of CD. The S-shaped curve traces the phosphorescence intensity of the phenanthrene-DBE solution as β-cyclodextrin is added. The initial steep slope has been attributed to the sharply-increasing probability that a phenanthrene molecule exiting the cavity of a CD-DBE molecule will find another CD-DBE molecule in close proximity.4


Conclusion
Cyclodextrin-enhanced room-temperature phosphorescence shows promise as a sensitive analytical technique. Sample preparation is simple, data-acquisition and processing are easily automated with a FLUOROLOG spectrometer, and the result is an intense, well-structured RTP signal. CD-RTP offers the advantages of increased selectivity based on molecular geometry, and partial immunity to quenching by dissolved O2 molecules.


Acknowledgement
The Fluorescence Group would like to thank Dr. L.J. Cline Love and Stephen Scypinski for their generous cooperation in the preparation of this technical note. We would also like to acknowledge permission from the American Chemical Society to reprint figures originally published in Analytical Chemistry


1 Hoshino, M.; Imamura, M.; Ikehara, K.; Hama, Y. J. Phys. Chem. 1981, 85 , 1820.
2 Turro, N.J.; Bolt, J.D.; Duroda, Y.;Tabushi, I. Photochem. Photobiol. 1982, 35 , 69.
3
Turro, N.J.; Cox., G.S.; Li, X. Photochem. Photobiol. 1983, 37 , 149.
4
Scypinski, S.; Cline Love, L.J. Anal. Chem. 1984, 56 , 322.
5
Scypinski, S.; Cline Love, L.J. Anal. Chem. 1984, 56 , 331.


back to top
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Using Gradient PCR to determine the optimum annealing temperature.
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cyclodextrin enhances room temperature phosphorescence

(Date:10/25/2014)... 2014 Investor-Edge has initiated coverage ... CYTR ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ... Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM ), and ... companies can be accessed at: http://investor-edge.com/register . ... ended on a positive note as the Dow Jones ...
(Date:10/22/2014)... DUBLIN and BOSTON , ... ACT ), a leading global specialty pharmaceutical company, and ... been granted an exclusive option to acquire Rhythm,s wholly ... (RM-131), a peptide ghrelin agonist, for the treatment of ... Rhythm has completed a successful Phase 2 trial ...
(Date:10/22/2014)... NJ (PRWEB) October 22, 2014 ... and services – has been working with a team ... and New Haven Farms Community Farming Collaborative to provide ... ePRO solution. The study, which started in May, ... program that provides participants weekly exposure to and participation ...
(Date:10/22/2014)...   Synthetic Biologics, Inc. (NYSE MKT: SYN), ... infections and diseases, announced today that the U.S. Patent ... for a composition of matter patent application that covers ... SYN-004. This is Synthetic Biologics, first allowed patent application ... to the Company,s extensive C. difficile patent ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
... the University of Illinois helped lead a collaborative ... for serious Staphylococcus aureus (Staph) infections. The research, ... of Science magazine, comes at a time when ... methicillin-resistant S. aureus) are spreading in epidemic proportions ...
... Pipeline ... Continues to Mature, SOUTH SAN FRANCISCO, Calif., Feb. 14 ... full,year and fourth quarter ended December 31, 2007., Revenues for the ... revenues for the full year was primarily due to,revenue recognition associated with ...
... IRVINE, Calif., Feb. 14 SectorWatch.biz announces the,availability ... the news and,driving markets today., Investors can ... by,visiting: http://www.SectorWatch.biz -- Click on MarketStats, ... include:,CardioVascular Bio Therapeutics, Inc. (OTC Bulletin Board: CVBT), ...
Cached Biology Technology:New approach may render disease-causing staph harmless 2New approach may render disease-causing staph harmless 3Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 2Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 3Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 4Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 5Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 6Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 7Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 8Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results 9SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA 2
(Date:10/18/2014)... sample of patients with undiagnosed, suspected genetic conditions, a ... a higher molecular diagnostic yield than traditional molecular diagnostic ... . The study is being released to coincide with ... Exome sequencing, which sequences the protein­coding region of the ... present in a cell or organism), has been rapidly ...
(Date:10/17/2014)... the University of Copenhagen have shown for the first ... of Cystic fibrosis patients, giving them the opportunity to ... chronic infections. , The study also discovered the bacterial ... patients was halted or slowed down by the immune ... the oxygen and helped "suffocate" the bacteria, forcing the ...
(Date:10/16/2014)... Researchers at William and Mary,s Virginia Institute of ... from the Environmental Protection Agency to identify the ... and to develop tools to help local governments ... project depends critically on a dataset of tidal-marsh ... 1970s. Only with this historical baseline can today,s ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3
... with research associate Jerilyn Walker and assistant professor Miriam Konkel, ... ancient jumping genes called Alu, which are more than 16 ... the Zoological Society of San Diego and the Institute of ... open access journal Mobile DNA . These tiny ...
... are being investigated as a way of improving drug response ... launched today (Monday). Scientists at the Cancer Research UK ... (ECMC) in Leicester will investigate whether tablets containing curcumin ... to the standard treatment for bowel cancer that has spread. ...
... is available in German . Halle/Saale. In ... special strategies. These differ in part considerably from the propagation ... Dr. Sonja Knapp of the Helmholtz Centre for Environmental Research ... current issue of the scientific journal Ecology Letters . ...
Cached Biology News:LSU research finds orangutans host ancient jumping genes 2Trial launched into curry chemical's cancer-fighting properties 2Different recipes for success in the world of plants 2Different recipes for success in the world of plants 3
BD BioCoat Laminin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... Cytokeratin TYPE II Reacts with most ... epidermal cell keratin of 86 and 58kD ... Broad keratin reactivity is found on human ... Immunogen: Human epidermal cells ...
Biology Products: